Published in Infect Immun on December 01, 2001
Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection. Clin Vaccine Immunol (2008) 0.84
Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection. J Clin Microbiol (2010) 0.83
Superantigen-mediated differentiation of bovine monocytes into dendritic cells. J Leukoc Biol (2009) 0.83
Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio. BMC Immunol (2006) 0.81
Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm. Toxins (Basel) (2010) 0.80
Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes. Mediators Inflamm (2008) 0.79
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Functional diversity of helper T lymphocytes. Nature (1996) 18.09
Interleukin-10. Annu Rev Immunol (1993) 10.14
A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet (1981) 7.69
Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity (1998) 5.75
V beta-specific stimulation of human T cells by staphylococcal toxins. Science (1989) 5.34
Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol (1992) 4.92
Lymphokine production by human T cells in disease states. Annu Rev Immunol (1994) 4.90
Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol (1993) 3.36
Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem (1992) 3.18
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome. J Clin Invest (1984) 2.33
A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun (1987) 2.13
Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol (1994) 2.11
Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol (1998) 2.05
Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol (1993) 1.94
Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1. Eur J Immunol (1993) 1.54
IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol (1996) 1.54
Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis (1989) 1.42
Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol (1994) 1.37
The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature (1990) 1.34
Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun (1993) 1.33
Superantigen mediated shock: a cytokine release syndrome. Immunobiology (1993) 1.29
Immunomodulatory properties of interferon-gamma. An update. Ann N Y Acad Sci (1998) 1.29
Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol (1997) 1.29
Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells (1999) 1.29
Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J Exp Med (1999) 1.24
Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells. Cytometry (1999) 1.18
Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology (1994) 1.18
Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect Immun (2000) 1.18
Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes. Infect Immun (1992) 1.11
Inhibition of toxic shock syndrome toxin-1-induced cytokine production and T cell activation by interleukin-10, interleukin-4, and dexamethasone. J Infect Dis (1995) 1.09
IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T cells. Distinct requirement for costimulatory signals through adhesion molecules. J Immunol (1994) 1.05
Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun (1995) 1.04
A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect Immun (1995) 0.99
Regulation of helper T cell responses to staphylococcal superantigens. Eur Cytokine Netw (2001) 0.99
Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect Immun (1995) 0.96
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity. Int Immunol (2001) 0.94
Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma. J Immunol (1996) 0.92
Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation. J Interferon Cytokine Res (1996) 0.91
Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1. J Clin Microbiol (1993) 0.89
Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality. Can J Microbiol (2000) 0.88
Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice. Infect Immun (1996) 0.87
Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10. Eur J Immunol (1996) 0.85
Differential inhibitory effects of interleukin-10, interleukin-4, and dexamethasone on staphylococcal enterotoxin-induced cytokine production and T cell activation. J Leukoc Biol (1995) 0.84
IL-2-independent activation and proliferation in human T cells induced by CD28. J Immunol (1999) 0.83
A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity. J Infect Dis (1996) 0.82
Mechanisms of pathogenesis of staphylococcal and streptococcal superantigens. Curr Top Microbiol Immunol (1998) 0.79
Microbial superantigens stimulate T cells by the superantigen bridge and independently by a cytokine pathway. J Interferon Cytokine Res (1997) 0.79
Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol (1992) 4.13
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis (2000) 4.01
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis (1975) 3.11
HSP60 gene sequences as universal targets for microbial species identification: studies with coagulase-negative staphylococci. J Clin Microbiol (1996) 3.03
Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. Am J Med (1976) 2.58
Endocervical Neisseria meningitidis with meningococcemia. N Engl J Med (1971) 2.51
Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations. Am J Med (1978) 2.46
Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) (1974) 2.21
Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother (1978) 2.13
Anorectal gonococcal infection. Ann Intern Med (1977) 1.96
High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation (2009) 1.83
Combined use of gentamicin and carbenicillin. Ann Intern Med (1971) 1.81
Gardnerella vaginalis has a gram-positive cell-wall ultrastructure and lacks classical cell-wall lipopolysaccharide. J Med Microbiol (1989) 1.75
Species identification and phylogenetic relationships based on partial HSP60 gene sequences within the genus Staphylococcus. Int J Syst Bacteriol (1999) 1.75
Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis (1974) 1.74
Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother (1978) 1.72
Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents. Antimicrob Agents Chemother (1977) 1.67
Orofacial odontogenic infections. Ann Intern Med (1978) 1.67
Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis (1993) 1.60
Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline. Antimicrob Agents Chemother (1975) 1.59
Erythromycin. Med Clin North Am (1982) 1.58
Cephalothin and cephaloridine therapy for bacterial meningitis. Ann Intern Med (1975) 1.58
Necrotizing pneumonia and empyema due to Clostridium perfringens. Report of a case and review of the literature. Am J Med (1975) 1.56
Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis (1995) 1.53
Role of anaerobic bacteria in spontaneous peritonitis of cirrhosis: report of two cases and review of the literature. Am J Med (1977) 1.53
Adoption of guidelines for Universal Precautions and Body Substance Isolation in Canadian acute-care hospitals. Infect Control Hosp Epidemiol (1990) 1.47
The bacteriology of acute pelvic inflammatory disease. Am J Obstet Gynecol (1975) 1.46
Sepsis associated with decubitus ulcers. Am J Med (1976) 1.44
Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria. Antimicrob Agents Chemother (1981) 1.40
Gut is not a source of cytokines in a porcine model of endotoxicosis. Surgery (1996) 1.40
Role of anaerobic bacteria in subdural empyema. Report of four cases and review of 327 cases from the English literature. Am J Med (1975) 1.39
Use and safety of antimicrobial agents during pregnancy. West J Med (1987) 1.38
Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis (1985) 1.33
Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob Agents Chemother (1983) 1.29
Neonatal scalp abscess following intrapartum fetal monitoring: prospective comparison of two spiral electrodes. Am J Obstet Gynecol (1977) 1.29
The significance of anaerobes in neonatal bacteremia: analysis of 23 cases and review of the literature. Pediatrics (1974) 1.28
Efficacy of microbial identification system for epidemiologic typing of coagulase-negative staphylococci. J Clin Microbiol (1994) 1.26
Primary meningococcal pericarditis presenting with tamponade. Chest (1975) 1.25
Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra. Antimicrob Agents Chemother (1978) 1.24
Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments. J Clin Microbiol (1989) 1.23
Parenteral clindamycin therapy for severe anaerobic infections. Arch Intern Med (1974) 1.23
A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. J Infect Dis (1979) 1.20
Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients. Antimicrob Agents Chemother (1973) 1.20
Spontaneous peritonitis of cirrhosis due to Campylobacter fetus. Gastroenterology (1976) 1.19
Survival of anaerobic and aerobic bacteria in a nonsupportive gassed transport system. J Clin Microbiol (1976) 1.18
Adult bacteremic Haemophilus parainfluenzae infections. Seven reports of cases and a review of the literature. Arch Intern Med (1979) 1.17
Subgaleal abscess: a preventable complication of scalp trauma. West J Med (1977) 1.17
Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes. Infect Immun (1992) 1.11
Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.11
Neonatal scalp abscess and fetal monitoring: factors associated with infection. Am J Obstet Gynecol (1977) 1.10
Anaerobic infections of the female genital tract: prospects and perspectives. Obstet Gynecol Surv (1975) 1.08
Rapid screening of Veillonella by ultraviolet fluorescence. J Clin Microbiol (1975) 1.08
Biases associated with several sampling methods used to estimate abundance of Ixodes scapularis and Amblyomma americanum (Acari: Ixodidae). J Med Entomol (1997) 1.08
Suppression of subadult Ixodes scapularis (Acari: Ixodidae) following removal of leaf litter. J Med Entomol (1995) 1.06
Epidemiologic typing systems for coagulase-negative staphylococci. Infect Control Hosp Epidemiol (1991) 1.06
Transmission of gram-negative bacilli to asthmatic children via home nebulizers. Ann Allergy (1991) 1.04
Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis (1992) 1.04
Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome. J Clin Microbiol (1983) 1.03
Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli. Antimicrob Agents Chemother (1980) 1.03
Case report. Haemophilus parainfluenzae epiglottitis with meningitis and bacteremia in an adult. Am J Med Sci (1974) 1.02
Cytosine arabinoside therapy for herpesvirus infections. Antimicrob Agents Chemother (Bethesda) (1970) 1.01
Microbiology of toxic shock syndrome: overview. Rev Infect Dis (1989) 1.01
In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins. J Antimicrob Chemother (1982) 1.00
Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors. Infect Immun (1992) 1.00
Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology (1993) 0.99
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria. Antimicrob Agents Chemother (1987) 0.99
Regulation of helper T cell responses to staphylococcal superantigens. Eur Cytokine Netw (2001) 0.99
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J (2000) 0.98
Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J Infect Dis (1984) 0.98
Variant postpartum toxic shock syndrome with probable intrapartum transmission to the neonate. Am J Obstet Gynecol (1984) 0.96
Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Infect Immun (2000) 0.95
Comparative in vitro activity of five cephalosporins against Lactobacilli. Antimicrob Agents Chemother (1979) 0.95
Sternoarticular septic arthritis in heroin users. N Engl J Med (1973) 0.95
Gram-negative bacillary septic arthritis: clinical, radiographic, therapeutic, and prognostic features. Semin Arthritis Rheum (1977) 0.95
Listeria monocytogenes endocarditis: report of a case and review of the literature. Am J Med Sci (1977) 0.95
The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. Genitourin Med (1991) 0.94
Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics. Antimicrob Agents Chemother (1986) 0.93
Toxic shock syndrome in the postoperative patient. Surg Gynecol Obstet (1982) 0.92
Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin Infect Dis (2001) 0.92
Antimicrobial therapy of gynaecological infections: an overview. J Antimicrob Chemother (1982) 0.91
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity. Antimicrob Agents Chemother (1991) 0.90
Gardnerella vaginalis-associated balanoposthitis. Sex Transm Dis (1986) 0.90
Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus. Infect Immun (1989) 0.90
Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1. J Clin Microbiol (1993) 0.89
Purification and purity assessment of toxic shock syndrome toxin 1. Rev Infect Dis (1989) 0.89
Binding competition of toxic shock syndrome toxin 1 and other staphylococcal exoproteins for receptors on human peripheral blood mononuclear cells. Infect Immun (1990) 0.88
Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients. Antimicrob Agents Chemother (1990) 0.88
Therapy of experimental infective endocarditis due to antibiotic-tolerant Lactobacillus plantarum-bactericidal synergy of penicillin plus gentamicin. Correlation of in vitro susceptibility studies with in vivo efficacy. Chemotherapy (1981) 0.88
Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality. Can J Microbiol (2000) 0.88
Sternoarticualr pyoarthrosis due to gram-negative bacilli. Report of eight cases. Arch Intern Med (1977) 0.88
Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab Dispos (1982) 0.87
Clinical and microbiologic risk evaluation for post-cesarean section endometritis by multivariate discriminant analysis: role of intraoperative mycoplasma, aerobes, and anaerobes. Am J Obstet Gynecol (1987) 0.87
Successful treatment of non-meningitic listerial brain abscess without operation. West J Med (1975) 0.87
Characterization of Neisseria meningitidis by polymerase chain reaction and restriction endonuclease digestion of the porA gene. J Clin Microbiol (1993) 0.87
Effects of selected meterological factors on diurnal questing of Ixodes scapularis and Amblyomma Americanum (Acari: Ixodidade). J Med Entomol (2001) 0.86
Auditing antibiotic use in a teaching hospital: focus on cefoxitin. Can Med Assoc J (1983) 0.86
False negative latex agglutination test in cryptococcal meningitis. Ann Neurol (1986) 0.86